CAC (Cosmo Bio Antibody Collection) represents a specialized portfolio of approximately 350 antibodies that are part of the larger collection of 4,200 antibodies offered by our parent company Cosmo Bio Co. Ltd. (Tokyo) to customers outside Japan.
What sets CAC antibodies apart is their careful selection for novel characteristics, whether it be target specificity, exceptional performance, or fulfilling an unmet need in research. By the time a CAC antibody is released for sale, it has been rigorously validated and comes with literature citations or other performance descriptions to support its efficacy.
These distinctive antibodies are originally developed by researchers at universities, research institutions, or pharmaceutical and biotech companies, with Cosmo Bio Co. Ltd in Japan handling the commercial preparation, quality control, and distribution. This collaborative manufacturing relationship allows Cosmo Bio to identify promising antibodies and partner with the original developers to bring these valuable research tools to market.
Cosmo Bio's dedicated technical support staff works as an extension of the original development teams, ensuring that product knowledge is maintained while providing standardized manufacturing and quality control. This arrangement allows Cosmo Bio to efficiently address specific inquiries about applications and performance characteristics while maintaining the exceptional quality that researchers expect.
Several CAC antibodies have achieved distinction as among the most frequently cited antibodies of their specificity, reflecting their reliability and importance in advancing scientific research. Researchers who choose CAC antibodies can expect high-quality products with proven performance records.
All CAC antibodies are identifiable by catalog numbers beginning with "CAC," making them easy to recognize within Cosmo Bio's extensive antibody offerings.